Email this article 
Biomarkers of Neonatal Sepsis: Review
Abstract
Neonatal sepsis is a bacterial bloodstream infection predominant to excessive clinical manifestations frequently associated with loss of existence or irreversible long-term deficits. Antibiotics are the drug of choice to address sepsis, no matter age. In neonates, the lack of dependable requirements for a unique prognosis and the supposition that an early antibiotic administration ought to restrict sepsis improvement in youngsters at chance have brought about an applicable antibiotic overuse for each prevention and therapy. the provision of biomarkers of neonatal sepsis that have to alert the physician to an early analysis of neonatal sepsis may additionally want to decorate the quick and long-term outcomes of real sepsis instances and restrict the indiscriminate and deleterious use of preventive antibiotics. The fundamental aim of this assessment is to summarize the crucial outcomes in this regard and to detail the accuracy of currently used biomarkers for the early prognosis of neonatal sepsis. Literature assessment showed that, irrespective of excessive studies, the diagnosis of neonatal sepsis and the behaviour of antibiotic remedy cannot be at current determined on the basis of a single biomarker. Given the significance of the hassle and the want to decrease the abuse of antibiotics, in addition studies are urgently required. but, as a substitute of looking for new biomarkers, it looks less complicated and greater productive to test combinations of or extra of the existing on hand biomarkers. furthermore, research based mostly on omics applied sciences have to be strongly boosted. but, while geared up for new statistics, the use of the clinical ratings prepared through some medical institutions must be counselled. Based totally on maternal risk factors and infant clinical signs, sepsis threat may be calculated, and a big reduction in antibiotic intake may be obtained.
Keywords
Full Text:
PDFReferences
-Weston, Emily J., et al. "The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008." The Pediatric infectious disease journal 30.11 (2011): 937.
-Oza, Shefali, et al. "Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000–2013." Bulletin of the World Health Organization 93 (2014): 19-28.
-Stoll, Barbara J., et al. "Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection." Jama 292.19 (2004): 2357-2365.
-Wynn, James L. "Defining neonatal sepsis." Current opinion in pediatrics 28.2 (2016): 135.
-Boghossian, Nansi S., et al. "Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births." The Journal of pediatrics 162.6 (2013): 1120-1124.
-Stoll, Barbara J., et al. "Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues." Pediatrics 127.5 (2011): 817-826.
-Mukhopadhyay, Sagori, Eric C. Eichenwald, and Karen M. Puopolo. "Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines." Journal of perinatology 33.3 (2013): 198-205.
-Kuzniewicz, Michael W., et al. "Development and implementation of an early-onset sepsis calculator to guide antibiotic management in late preterm and term neonates." Joint Commission journal on quality and patient safety 42.5 (2016): 232-239.
-Amare, Desalegne, Masresha Mela, and Getenet Dessie. "Unfinished agenda of the neonates in developing countries: magnitude of neonatal sepsis: systematic review and meta-analysis." Heliyon 5.9 (2019).
-Stoll, Barbara J., et al. "Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network." Pediatrics 110.2 (2002): 285-291.
-Tsai, Ming-Horng, et al. "Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis." The Pediatric infectious disease journal 33.1 (2014): e7-e13.
-Singer, Mervyn, et al. "The third international consensus definitions for sepsis and septic shock (Sepsis-3)." Jama 315.8 (2016): 801-810.
-Hofer, Nora, et al. "Performance of the definitions of the systemic inflammatory response syndrome and sepsis in neonates." Journal of perinatal medicine 40.5 (2012): 587-590.
-Wynn, James L., et al. "Time for a neonatal–specific consensus definition for sepsis." Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 15.6 (2014): 523.
-PrabhuDas, Mercy, et al. "Challenges in infant immunity: implications for responses to infection and vaccines." Nature immunology 12.3 (2011): 189-194.
-Steinberger, Eva, Nora Hofer, and Bernhard Resch. "Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants." Scandinavian journal of clinical and laboratory investigation 74.5 (2014): 432-436.
-Chiesa, Claudio, et al. "C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection." Clinical chemistry 49.1 (2003): 60-68.
-Morris, Rachel, et al. "Comparison of the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC) with NICE guideline CG149 in infants≥ 34 weeks’ gestation who developed early-onset sepsis." Archives of Disease in Childhood-Fetal and Neonatal Edition 105.6 (2020): 581-586.
-Hershkovich–Shporen, Calanit, et al. "Centers for disease control and prevention guidelines identified more neonates at risk of early‐onset sepsis than the Kaiser‐Permanente calculator." Acta Paediatrica 111.4 (2022): 767-771.
-Bakhuizen, Sabine E., et al. "Meta‐analysis shows that infants who have suffered neonatal sepsis face an increased risk of mortality and severe complications." Acta Paediatrica 103.12 (2014): 1211-1218.
-Porta, Alessandro, et al. "Off-label antibiotic use in children in three European countries." European journal of clinical pharmacology 66 (2010): 919-927.
-Chakkarapani, Aravanan Anbu, and Alison Bedford Russell. "Antibiotic stewardship in the neonatal intensive care unit." Paediatrics and Child Health 29.6 (2019): 269-273.
-Lee, Kelley R., Bindiya Bagga, and Sandra R. Arnold. "Reduction of broad-spectrum antimicrobial use in a tertiary children’s hospital post antimicrobial stewardship program guideline implementation." Pediatric critical care medicine 17.3 (2016): 187-193.
-Beerlage-de Jong, Nienke, et al. "Technology to support integrated antimicrobial stewardship programs: a user centered and stakeholder driven development approach." Infectious disease reports 9.1 (2017): 6829.
-Ho, Timmy, et al. "Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations." Pediatrics 142.6 (2018).
-Schulman, Joseph, et al. "Neonatal intensive care unit antibiotic use." Pediatrics 135.5 (2015): 826-833.
-Cotten, Charles M. "Adverse consequences of neonatal antibiotic exposure." Current opinion in pediatrics 28.2 (2016): 141-149.
-Sharma, Deepak, et al. "Biomarkers for diagnosis of neonatal sepsis: a literature review." The Journal of Maternal-Fetal & Neonatal Medicine 31.12 (2018): 1646-1659.
-Kellogg, James A., et al. "Frequency of low level bacteremia in infants from birth to two months of age." The Pediatric infectious disease journal 16.4 (1997): 381-385.
-Woodford, Emily C., et al. "Neonatal blood culture inoculant volume: feasibility and challenges." Pediatric research 90.5 (2021): 1086-1092.
-Yager, Paul, et al. "Microfluidic diagnostic technologies for global public health." Nature 442.7101 (2006): 412-418.
-Pammi, Mohan, et al. "Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis." Pediatrics 128.4 (2011): e973-e985.
-Da Silva, Orlando, Arne Ohlsson, and Cynthia Kenyon. "Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review." The Pediatric infectious disease journal 14.5 (1995): 362-366.
-GREENBERG, DAVID N., and MAJOR BRADLEY A. YODER. "Changes in the differential white blood cell count in screening for group B streptococcal sepsis." The Pediatric infectious disease journal 9.12 (1990): 886-889.
-Escobar, Gabriel J., et al. "Early discontinuation of antibiotic treatment in newborn admitted to rule out sepsis: a decision rule." The Pediatric infectious disease journal 13.10 (1994): 860-866.
-Escobar, Gabriel J., et al. "Neonatal sepsis workups in infants≥ 2000 grams at birth: a population-based study." Pediatrics 106.2 (2000): 256-263.
-Newman, Thomas B., et al. "Interpreting complete blood counts soon after birth in newborns at risk for sepsis." Pediatrics 126.5 (2010): 903-909.
-Hornik, Christoph P., et al. "Use of the complete blood cell count in early-onset neonatal sepsis." The Pediatric infectious disease journal 31.8 (2012): 799.
-Murphy, Kara, and Joel Weiner. "Use of leukocyte counts in evaluation of early-onset neonatal sepsis." The Pediatric infectious disease journal 31.1 (2012): 16-19.
-Jethani, Sumit, Namita Bhutani, and Abhishek Yadav. "Diagnostic utility of combined immature and total neutrophil counts along with C-reactive protein in early detection of neonatal sepsis: A cross-sectional study." Annals of Medicine and Surgery 77 (2022): 103589.
-van der Meer, Wim, et al. "Does the band cell survive the 21st century?." European journal of haematology 76.3 (2006): 251-254.
-Black, Steven, Irving Kushner, and David Samols. "C-reactive protein." Journal of Biological Chemistry 279.47 (2004): 48487-48490.
-Sharma, Anita, et al. "Evaluation of sepsis screen for diagnosis of neonatal septicemia." The Indian Journal of Pediatrics 60 (1993): 559-563.
-Perrone, Serafina, et al. "C reactive protein in healthy term newborns during the first 48 hours of life." Archives of Disease in Childhood-Fetal and Neonatal Edition 103.2 (2018): F163-F166.
-Simonsen, Kari A., et al. "Early-onset neonatal sepsis." Clinical microbiology reviews 27.1 (2014): 21-47.
-Bomela, Hlwelekazi N., et al. "Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis." The Pediatric infectious disease journal 19.6 (2000): 531-535.
-Hofer, Nora, et al. "An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks." Neonatology 102.1 (2012): 25-36.
-Whicher, John, Jacques Bienvenu, and Guillaume Monneret. "Procalcitonin as an acute phase marker." Annals of clinical biochemistry 38.5 (2001): 483-493.
-Christ-Carin, M. "Procalcitonin in bacterial infections-hype, hope, more or less?." Swiss medical weekly 135.3132 (2005): 451-451.
-Esposito, Susanna, et al. "Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia." Respiratory medicine 105.12 (2011): 1939-1945.
-Oberhoffer, Mathias, et al. "Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro." Journal of laboratory and Clinical Medicine 134.1 (1999): 49-55.
-Chiesa, Claudio, et al. "Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates." Clinical Infectious Diseases 26.3 (1998): 664-672.
-Chiesa, Claudio, et al. "C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period." Clinica Chimica Acta 412.11-12 (2011): 1053-1059.
-Turner, Dan, et al. "Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram." Archives of Disease in Childhood-Fetal and Neonatal Edition 91.4 (2006): F283-F286.
-Lapillonne, Alexandre, et al. "Lack of specificity of procalcitonin for sepsis diagnosis in premature infants." The Lancet 351.9110 (1998): 1211-1212.
-Monneret, Guillaume, et al. "Increased Serum Procalcitonin Levels Are Not Specific to Sepsis in Neonates [with Reply]." Clinical infectious diseases (1998): 1559-1561.
-Vazzalwar, Ramesh, et al. "Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants." Journal of perinatology 25.6 (2005): 397-402.
-Eschborn, Samantha, and Joern-Hendrik Weitkamp. "Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis." Journal of Perinatology 39.7 (2019): 893-903.
-Reyes, C. Santana, et al. "Role of cytokines (interleukin‐1β, 6, 8, tumour necrosis factor‐α, and soluble receptor of interleukin‐2) and C‐reactive protein in the diagnosis of neonatal sepsis." Acta Paediatrica 92.2 (2003): 221-227.
-Sack Jr, George H. "Serum amyloid A–a review." Molecular medicine 24.1 (2018): 46.
-Lannergård, Anders, et al. "Serum amyloid A (SAA) protein and high‐sensitivity C‐reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults." Acta Paediatrica 94.9 (2005): 1198-1202.
-Cetinkaya, M., et al. "Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants." Journal of Perinatology 29.3 (2009): 225-231.
-Bengnér, Johannes, et al. "Serum amyloid A–A prime candidate for identification of neonatal sepsis." Clinical Immunology 229 (2021): 108787.
-Bourika, Vasiliki, et al. "Clinical value of serum amyloid-A protein, high-density lipoprotein cholesterol and apolipoprotein-A1 in the diagnosis and follow-up of neonatal sepsis." The Pediatric Infectious Disease Journal 39.8 (2020): 749-755.
-Bengnér, Johannes, et al. "Serum amyloid A–A prime candidate for identification of neonatal sepsis." Clinical Immunology 229 (2021): 108787.
-Fendler, Wojciech M., and Andrzej J. Piotrowski. "Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates." Journal of paediatrics and child health 44.3 (2008): 114-118.
-Yuan, Haining, et al. "Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis." BioMed research international 2013 (2013).
-Zudaire, Enrique, Sergio Portal-Nunez, and Frank Cuttitta. "The central role of noradrenalin in host defense." Journal of leukocyte biology 80.2 (2006): 237-244.
-Fahmey, Sameh Samir, et al. "Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis." Korean journal of pediatrics 61.5 (2018): 156.
-Kannan, Raja, et al. "Diagnostic and prognostic validity of Proadrenomedullin among neonates with Sepsis in tertiary care hospitals of southern India." International Journal of Pediatrics 2018 (2018).
-Cetin, Orkun, et al. "Serial ultrasonographic examination of the fetal thymus in the prediction of early neonatal sepsis in preterm premature rupture of membranes." Gynecologic and Obstetric Investigation 78.3 (2014): 201-207.
-Wu, Tai-Wei, et al. "The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis." The Journal of pediatrics 162.1 (2013): 67-71.
-Rao, Lubei, et al. "Progranulin as a novel biomarker in diagnosis of early-onset neonatal sepsis." Cytokine 128 (2020): 155000.
-Badr, Hassan S., Fady M. El-Gendy, and Mohamed A. Helwa. "Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis." The Journal of Maternal-Fetal & Neonatal Medicine 31.16 (2018): 2209-2215.
-Zonda, Gabriela Ildiko, et al. "Endocan-a potential diagnostic marker for early onset sepsis in neonates." The Journal of Infection in Developing Countries 13.04 (2019): 311-317.
-Fahmey, S. S., and N. Mostafa. "Pentraxin 3 as a novel diagnostic marker in neonatal sepsis." Journal of neonatal-perinatal medicine 12.4 (2019): 437-442.
-Wu, Lijie, et al. "Diagnostic Value of Inflammatory Markers and Cytokines in Neonatal Sepsis." Evidence-Based Complementary and Alternative Medicine 2022 (2022).
-Liu, Guozhen, et al. "Point‐of‐care detection of cytokines in cytokine storm management and beyond: Significance and challenges." View 2.4 (2021): 20210003.
-Küster, Helmut, et al. "Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation." The Lancet 352.9136 (1998): 1271-1277.
-Ng, Pak C., and Hugh S. Lam. "Biomarkers for late-onset neonatal sepsis: cytokines and beyond." Clinics in perinatology 37.3 (2010): 599-610.
-Eichberger, Julia, and Bernhard Resch. "Reliability of interleukin-6 alone and in combination for diagnosis of early onset neonatal sepsis: systematic review." Frontiers in Pediatrics 10 (2022): 840778.
-Raynor, Laura L., et al. "Cytokine screening identifies NICU patients with Gram-negative bacteremia." Pediatric research 71.3 (2012): 261-266.
-Zhou, Min, et al. "Interleukin-8 for diagnosis of neonatal sepsis: a meta-analysis." PloS one 10.5 (2015): e0127170.
-Dillenseger, Laurence, et al. "Early inflammatory markers for the diagnosis of late-onset sepsis in neonates: the nosodiag study." Frontiers in pediatrics 6 (2018): 346.
-Schindler, Ralf, et al. "Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF." (1990): 40-47.
-Formosa, Amanda, Paul Turgeon, and Claudia C. Dos Santos. "Role of miRNA dysregulation in sepsis." Molecular Medicine 28.1 (2022): 99.
-Jouza, Martin, et al. "MicroRNA as an early biomarker of neonatal sepsis." Frontiers in pediatrics 10 (2022): 854324.
-Gude, Sai Sravya, et al. "Biomarkers of neonatal sepsis: From being mere numbers to becoming guiding diagnostics." Cureus 14.3 (2022).
-Chenevier-Gobeaux, Camille, et al. "Presepsin (sCD14-ST), an innate immune response marker in sepsis." Clinica chimica acta 450 (2015): 97-103.
-Schulman, Joseph, et al. "Newborn antibiotic exposures and association with proven bloodstream infection." Pediatrics 144.5 (2019).
-Parri, Niccolò, et al. "Accuracy of presepsin in neonatal sepsis: Systematic review and meta-analysis." Expert Review of Anti-Infective Therapy 17.4 (2019): 223-232.
-Ergor, Serap Nur, et al. "Reference ranges of presepsin (soluble CD14 subtype) in term and preterm neonates without infection, in relation to gestational and postnatal age, in the first 28 days of life." Clinical Biochemistry 77 (2020): 7-13.
-Pugni, Lorenza, et al. "Presepsin (soluble CD14 subtype): reference ranges of a new sepsis marker in term and preterm neonates." PloS one 10.12 (2015): e0146020.
-Poggi, Chiara, et al. "Presepsin for the detection of late-onset sepsis in preterm newborns." Pediatrics 135.1 (2015): 68-75.
-Mussap, Michele, et al. "Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS." Clinica Chimica Acta 451 (2015): 65-70.
-Bouchon, Axel, et al. "TREM-1 amplifies inflammation and is a crucial mediator of septic shock." Nature 410.6832 (2001): 1103-1107.
-Garofoli, F., et al. "Preterm newborns are provided with triggering receptor expressed on myeloid cells-1." International Journal of Immunopathology and Pharmacology 23.4 (2010): 1297-1301.
-Adly, Amira AM, et al. "Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis." Cytokine 65.2 (2014): 184-191.
-Stein, Michal, et al. "The accuracy of C-reactive protein, procalcitonin, and s-TREM-1 in the prediction of serious bacterial infection in neonates." Clinical pediatrics 54.5 (2015): 439-444.
-Sarafidis, Kosmas, et al. "Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates." Intensive care medicine 36 (2010): 864-868.
-Lv, Bokun, et al. "Tumor necrosis factor-α as a diagnostic marker for neonatal sepsis: a meta-analysis." The Scientific World Journal 2014 (2014).
-Layseca‐Espinosa, Esther, et al. "Expression of CD64 as a potential marker of neonatal sepsis." Pediatric allergy and immunology 13.5 (2002): 319-327.
-Ng, Pak C., et al. "Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants." Pediatric research 51.3 (2002): 296-303.
-Ng, Pak C., et al. "Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection." Pediatric research 56.5 (2004): 796-803.
-Bhandari, Vineet, et al. "Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker." Pediatrics 121.1 (2008): 129-134.
-Elawady, Sanaa, et al. "Neutrophil CD64 as a diagnostic marker of sepsis in neonates." Journal of Investigative Medicine 62.3 (2014): 644-649.
-Smith, Claire L., et al. "Identification of a human neonatal immune-metabolic network associated with bacterial infection." Nature communications 5.1 (2014): 4649.
-Cernada, María, et al. "Genome-wide expression profiles in very low birth weight infants with neonatal sepsis." Pediatrics 133.5 (2014): e1203-e1211.
-Fatmi, Ahlam, et al. "Clinical and immunological aspects of microRNAs in neonatal sepsis." Biomedicine & Pharmacotherapy 145 (2022): 112444.
-Bushati, Natascha, and Stephen M. Cohen. "microRNA functions." Annu. Rev. Cell Dev. Biol. 23 (2007): 175-205.
-Antonakos, Nikolaos, et al. "Modes of action and diagnostic value of miRNAs in sepsis." Frontiers in Immunology (2022): 4172.
-Berkhout, Daniel JC, et al. "Late-onset sepsis in preterm infants can be detected preclinically by fecal volatile organic compound analysis: a prospective, multicenter cohort study." Clinical Infectious Diseases 68.1 (2019): 70-77.
-Frerichs, Nina M., et al. "Fecal Volatile Metabolomics Predict Gram-Negative Late-Onset Sepsis in Preterm Infants: A Nationwide Case-Control Study." Microorganisms 11.3 (2023): 572.
-Berkhout, Daniel JC, et al. "Late-onset sepsis in preterm infants can be detected preclinically by fecal volatile organic compound analysis: a prospective, multicenter cohort study." Clinical Infectious Diseases 68.1 (2019): 70-77.
-Frerichs, Nina M., et al. "Fecal Volatile Metabolomics Predict Gram-Negative Late-Onset Sepsis in Preterm Infants: A Nationwide Case-Control Study." Microorganisms 11.3 (2023): 572.
DOI: http://dx.doi.org/10.52155/ijpsat.v42.1.5821
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Maged Naser
This work is licensed under a Creative Commons Attribution 4.0 International License.